Skip to content
10-Q

Quarterly Report

Shuttle Pharmaceuticals, Inc.

0001615774-17-004376

← back to feed
Filed
Aug 14, 2017 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2017 · Aug 14, 2017 45M sh
Cash And Equivalents Q2 2017 · Jun 30, 2017 $172.82K
Cash And Equivalents Q2 2017 · Dec 31, 2016 $92.8K
Cash And Equivalents Q2 2017 · Jun 30, 2016 $26.72K
Cash And Equivalents Q2 2017 · Dec 31, 2015 $128.84K
Stockholders Equity Q2 2017 · Jun 30, 2017 −$253.45K
Stockholders Equity Q2 2017 · Dec 31, 2016 −$70.85K
Current Liabilities Q2 2017 · Jun 30, 2017 $475.54K
Current Liabilities Q2 2017 · Dec 31, 2016 $105.28K
Total Liabilities Q2 2017 · Jun 30, 2017 $595.79K
Total Liabilities Q2 2017 · Dec 31, 2016 $225.53K
Current Assets Q2 2017 · Jun 30, 2017 $313.26K
Current Assets Q2 2017 · Dec 31, 2016 $115.93K
Total Assets Q2 2017 · Jun 30, 2017 $342.34K
Total Assets Q2 2017 · Dec 31, 2016 $154.68K
Sga Expense Q2 2017 · Jun 30, 2017 $76.84K
Sga Expense Q2 2017 · Jun 30, 2017 $102.31K
Sga Expense Q2 2017 · Jun 30, 2016 $62.26K
Sga Expense Q2 2017 · Jun 30, 2016 $72.2K
Rd Expense Q2 2017 · Jun 30, 2017 $379.45K
Rd Expense Q2 2017 · Jun 30, 2017 $596.5K
Rd Expense Q2 2017 · Jun 30, 2016 $111.59K
Rd Expense Q2 2017 · Jun 30, 2016 $258.49K
Net Income Q2 2017 · Jun 30, 2017 −$78.14K
Net Income Q2 2017 · Jun 30, 2017 −$182.69K
Net Income Q2 2017 · Jun 30, 2016 −$102.52K
Net Income Q2 2017 · Jun 30, 2016 −$126.93K
Operating Income Q2 2017 · Jun 30, 2017 −$75.69K
Operating Income Q2 2017 · Jun 30, 2017 −$177.7K
Operating Income Q2 2017 · Jun 30, 2016 −$102.66K
Operating Income Q2 2017 · Jun 30, 2016 −$127.31K